FMN2 p.Pro947fs
c.2840del · VCV3779672
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | frameshift | predicted loss-of-function |
|---|---|---|
| NMD | predicted | premature termination codon in exon 5 of 18 |
| Splicing | ||
| SpliceAI | — | not assessed · substitutions only |
| Constraint at this position | ||
| Conservation | phyloP -15 | GERP -2.1 |
| Overall | ||
| CADD | 23.5 | PHRED · no single calibrated threshold — expert panels disagree |
| Region caveats | ||
| Repeat context | tandem | chrX:26504256 segmental duplication, simple repeat · ambiguous alignment · reads may not map uniquely · confidence, not pathogenicity |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.0645% | 1,550 |
| European (non-Finnish)grpmax | 0.0539% | 1,854 |
| Middle Eastern | 0.0239% | 4,188 |
| Remaining individualsnot grpmax-eligible | 0.0113% | 8,863 |
| Admixed American | 0.00678% | 14,745 |
| African / African-American | 0.00513% | 19,485 |
| South Asian | 0.0042% | 23,783 |
| Finnishnot grpmax-eligible | 0.00393% | 25,477 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- FMN2
- Protein
- p.Pro947fs
- Coding
- c.2840del
- MANE Select
- NM_020066
- Type
- Deletion
- Location
- chr1:240207648 (GRCh38)
- Gene constraint
- LOEUF 0.51 · pLI 0.51 (gnomAD)
- Structure
- AlphaFold pLDDT 51.48 · 2 PDB
- Residue 947
- the fh1 domain; the 'disordered' region
Similar variants
- FMN2 p.Pro517fs Pathogenic/Likely pathogenic ★★ same condition
- FMN2 p.Pro947Leu Benign/Likely benign ★★ same residue
- FMN2 p.Arg1148_Pro1169del Conflicting classifications of pathogenicity ★ same condition
- FMN2 p.Leu948fs Conflicting classifications of pathogenicity ★ same condition
- FMN2 p.Pro947_Pro958delinsLeu Uncertain significance ★ same residue
- FMN2 p.Pro947= Likely benign ★ same residue
- FMN2 p.Pro947Arg Likely benign ★ ⚠ same residue
- FMN2 p.Thr839fs Pathogenic same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/fmn2-p-pro947fs (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown